NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院

Clinical TrialsSearch results

Search

Number of results: 67288
  • Recruitment status
  • Title of the study
  • Health Condition
  • Primary sponsor
  • Date of registration
  • Other

  • Patients with osteoporosis at higher fracture risk
  • ASAHI KASEI PHARMA CORPORATION
  • 2016-12-22
  • Other

  • Patients with non-small cell lung cancer who have received platinum-based chemotherapy
  • Yakult Honsha Co., Ltd.
  • 2013-05-10
  • Other

  • Patients with non-malignant pain
  • SHIONOGI & CO., LTD.
  • 2014-07-08
  • Other

  • Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease
  • Eli Lilly Japan K.K.
  • 2017-04-04
  • Other

  • Patients with malignant soft tissue sarcomas of histological types that have been reported to carry chromosomal translocations
  • Taiho Pharmaceutical Co., Ltd.
  • 2012-05-31
  • Other

  • Patients with malignant soft tissue sarcomas of histological types that have been reported to carry chromosomal translocations
  • Taiho Pharmaceutical Co., Ltd.
  • 2012-06-04
  • Other

  • Patients with malignant soft tissue sarcomas of histological types that have been reported to carry chromosomal translocations
  • Taiho Pharmaceutical Co., Ltd.
  • 2014-04-18
  • Other

  • patients with HER2-positive metastatic cancer who enrolled in a trastuzumab emtansine Genentech/Roche-sponsored study and have received either trastuzumab emtansine as part of the study or have received control arm treatment with the option to receive trastuzumab emtansine according to the parent study protocol, and who either have completed the required parent study assessments or continue to receive study treatment at the time of the parent study closure without evidence of disease progression or unacceptable toxicity
  • CHUGAI PHARMACEUTICAL CO., LTD.
  • 2016-02-24
  • Other

  • Patients with following chronic hepatitis C (1)Patients with high blood HCV-RNA level (2)Patients who had no efficacy or had relapse after previous monotherapy of interferon preparation
  • Dainippon Sumitomo Pharma Co., Ltd.
  • 2005-09-12
  • Other

  • Patients with Crohn's disease in remission phase
  • Zeria Pharmaceutical Co., Ltd.
  • 2005-12-19

Progress situation









The subject of age and gender

Sex



Age











Clinical Study Category (based on jRCT)